Eye test could help detect signs of Alzheimer's

Article

Research published in the journal Cell Death and Disease by University College of London scientists indicates that a simple eye test may, in future, be able to detect Alzheimer's, amongst other diseases.

Research published in the journal Cell Death and Disease by University College of London scientists indicates that a simple eye test may, in future, be able to detect Alzheimer's, amongst other diseases.

Professor Francesca Coredeiro, lead author from University College London Institute of Ophthalmology told the BBC: "Few people realise that the retina is a direct, albeit thin, extension of the brain.

“It is entirely possible that in the future a visit to a high-street optician to check on your eyesight will also be a check on the state of your brain.”

“I hope that screening for Alzheimer's will be available on the high street within five years.”

In a statement the Alzheimer Society said: “We know as Alzheimer's disease develops, cells in the brain die and the brain shrinks. The study of this disease has been hampered by the difficulty of following the progress directly in the human brain. This research is very exciting as it opens up the possibility of observing individual cells on the human retina using a relatively non-invasive procedure. In the longer term this technique could be used for diagnostic purposes or to help researchers monitor the effects of drugs under development. However, much more research needs to be done before we know if we can get to this stage.

“A million people will develop dementia in the next 10 years yet research remains drastically underfunded. If we can delay the onset of dementia by five years we can halve the number of people who will die with the disease.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.